Abstract
Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Current Psychopharmacology
Title:Safety with Zopiclone Use: Contemporary Issues
Volume: 6
Author(s): Nevio Cimolai*
Affiliation:
- Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver,Canada
Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Abstract: Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Export Options
About this article
Cite this article as:
Cimolai Nevio*, Safety with Zopiclone Use: Contemporary Issues, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556005666160822112843
DOI https://dx.doi.org/10.2174/2211556005666160822112843 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Updated Unified Pharmacophore Model of the Benzodiazepine Binding Site on γ-Aminobutyric Acida Receptors: Correlation with Comparative Models
Current Medicinal Chemistry Photoreactors for Wastewater Treatment: A Review
Recent Patents on Engineering Traditional and Alternative Therapies for Refractory Angina
Current Pharmaceutical Design The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-γ Inducible Chemokines and their Receptor
Current Pharmaceutical Design Effects of Opiates and HIV Proteins on Neurons: The Role of Ferritin Heavy Chain and a Potential for Synergism
Current HIV Research Metabolomics and Its Practical Value in Pharmaceutical Industry
Current Drug Metabolism Molecular Hydrogen as a Neuroprotective Agent
Current Neuropharmacology Putative Immune Regulatory Role of Statins
Current Immunology Reviews (Discontinued) Proteomic Comparison of the Aleurone Layer in Triticum Aestivum and Triticum Monococcum Wheat Varieties
Current Proteomics Glutamate-regulated Behavior, Transmitter Release, Gene Expression and Addictive Plasticity in the Striatum: Roles of Metabotropic Glutamate Receptors
Current Neuropharmacology <i>LncRNA</i> Xist, X-chromosome Instability and Alzheimer’s Disease
Current Alzheimer Research P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer
Current Drug Targets The Effects of the Endocrine Disruptors Dithiocarbamates on the Mammalian Ovary with Particular Regard to Mancozeb
Current Pharmaceutical Design Paring Down Obesity and Metabolic Disease by Targeting Inflammation and Oxidative Stress
Current Neurovascular Research Azoles: Mode of Antifungal Action and Resistance Development. Effect of Miconazole on Endogenous Reactive Oxygen Species Production in Candida albicans
Anti-Infective Agents in Medicinal Chemistry Could Sigma Receptor Ligands be a Treatment for Methamphetamine Addiction?
Current Drug Abuse Reviews Neurotransmitters and Microglial-Mediated Neuroinflammation
Current Protein & Peptide Science Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Gastrointestinal Non Colorectal Cancer. Do Elderly Patients Need a Specific Management?
Anti-Cancer Agents in Medicinal Chemistry Regulation of RhoA Activity by Adhesion Molecules and Mechanotransduction
Current Molecular Medicine